Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online September 15, 2020.
Article Versions
- Latest version (December 15, 2019 - 04:00).
- You are currently viewing a Latest version of this article (September 15, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- Gaël Mouterde,
- Etienne Gamon,
- Nathalie Rincheval,
- Cédric Lukas,
- Raphaele Seror,
- Francis Berenbaum,
- Anne-Marie Dupuy,
- Claire Daien,
- Jean-Pierre Daurès and
- Bernard Combe
- An unrestricted grant from Merck Sharp and Dohme (MSD) was allocated for the first 5 years of the ESPOIR cohort study. Two additional grants from INSERM were obtained to support part of the biological database. The French Society of Rheumatology, Pfizer, AbbVie, and more recently, Roche-Chugai and Lilly also supported the ESPOIR cohort study.
G. Mouterde, MD, E. Gamon, MD, Cedric Lukas, MD, PhD, C. Daien, MD, Bernard Combe, MD, PhD, Rheumatology Department, CHU Montpellier, University of Montpellier, Montpellier; N. Rincheval, J.P. Daurès, MD, PhD, Biostatistics, University Institute of Clinical Research, EA 2415, Montpellier; R. Seror, MD, PhD, Rheumatology, Hôpital Kremlin Bicêtre, Paris; F. Berenbaum, MD, PhD, Sorbonne Université, INSERM, DHU i2B, AP-HP, Hôpital Saint-Antoine, F-75012, Paris; A.M. Dupuy, MD, Department of Biochemistry, CHU Montpellier, Montpellier, France.
Address correspondence to Dr. G. Mouterde, Rheumatology Department, Lapeyronie Hospital, 371 avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France. Email: g-mouterde@chu-montpellier.fr.
Accepted for publication December 6, 2019.